SCHEMBL4417926

SCHEMBL4417926

IC1CCCCOO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359800 0.92
SCHEMBL4783104 0.79
SCHEMBL24741443 0.71
SCHEMBL5184661 0.71
SCHEMBL18658857 0.71
SCHEMBL14908536 0.69
SCHEMBL9047920 0.67
SCHEMBL8906864 0.67
SCHEMBL19100153 0.67
SCHEMBL10957942 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016196955-A1 Inhibitors of RAD52 Recombination Protein and Methods Using Same DREXEL UNIVERSITY (US) 2016-12-08 WO disclosed
EP-2135861-B1 Process for the synthesis of the 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and its application to the synthesis of ivabradine as well as its addition salts with a pharmaceutically acceptable acid SERVIER LAB (FR) 2014-07-30 EP disclosed
EP-2135861-A1 Process for the synthesis of the 7,8-dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one, and its application to the synthesis of ivabradine as well as its addition salts with a pharmaceutically acceptable acid Les Laboratoires Servier (FR) 2009-12-23 EP disclosed